Skip to main content

Table 1 Characteristics of the included studies

From: The effect of Parkinson’s disease on total knee arthroplasty: a systematic review and meta-analysis

Journal

Year

Author

Study design

Level of evidence

Disease severity

Follow-up duration

Number (PD)

Number (control)

Age in years

Acta Orthop. Belg

2013

Craig

Retrospective case-controlled study

III

No information

5 years

32

33

Mean 73

JBJS

2014

Jämsen

Registry-based case-controlled study

III

No information

PD: median 5.4 years

Control: median 5.5 years

560

1680

PD: median 72

Control: median 73

J Arthroplasty

2017

Rodon

Retrospective case-controlled study

III

Charlson Comorbidity index

PD: 3.72 ± 0.14

Control: 3.84 ± 0.12

5.3years

71

132

PD: 68.5 ± 1.13

Control: 69.7 ± 0.77

J Arthroplasty

2018

Wong

Retrospective cohort study

III

No information

1 year

35

41

PD: 72.6 ± 7.3

Control: 71.8 ± 7.6

J Orthop Surg Res

2019

Xiao

Retrospective case series

IV

Hoehn and Yahr stage

I: 2, II: 7, III: 5, IV: 4

Median 38 months

18

 

67.89 ± 6.62

KSSTA

2019

Newman

Registry-based case-controlled study

III

Charlson Comorbidity index

PD: 0: 59% (18,928), 1: 26% (8288), ≥ 2: 15% (4705)

Control: 0.59% (56,707), 1: 26% (24,827), ≥ 2: 15% (14,062)

 

31,921

95,596

PD: 72 ± 8.1

Control: 72 ± 8.1

Knee

2019

Kleiner

Registry-based case-controlled study

III

Charlson Comorbidity index

PD: 0.56 ± 0.01

Control: 0.58 ± 0.00

 

7361

73,610

PD: 72.0 ± 0.1

Control: 72.1 ± 0.03

AOTS

2020

Veronica

Retrospective cohort study

IV

Modified Hoehn and Yahr stage 1.5

3.5 years

26

 

71 (range 61–83)

JKS

2020

Marchand

Registry-based case-controlled study

III

Elixhauser Comorbidity index

PD: 9 ± 4

Control: 9 ± 4

2 years

18,082

54,244

 < 64: PD (2255), Control (6765)

65–69: PD (4740), Control (14,220)

70–74: PD (4483), Control (13,448)

75–79: PD (3867), Control (11,601)

80–84: PD (2008), Control (6024)

 < 85: PD (565), Control (4695)

Unknown: PD (164), Control (491)

J Arthroplasty

2020

Goh

Retrospective case-controlled study

III

Hoehn and Yahr stage

I: 34, II: 12, III: 9, IV: 2

2 years

57

57

PD: 69.3 ± 7.7

Control: 70.1 ± 8.6

J Orthop Sci

2020

Ergin

Retrospective case-controlled study

III

Columbia stage in PD

I: 2, II: 7, III: 4

PD: 64.5 ± 44.7 months

Control: 51.8 ± 13.6 months

13

13

PD: 75.6 ± 8.13

Control: 71.4 ± 9.07

Int Orthop

2021

Baek

Retrospective case-controlled study

III

Koval’s grade

PD: I (25), II (4)

Control: I (51), II (7)

PD: mean 133.0 months

Control: mean 133.1 months

29

58

PD: 71.0 ± 5.8

Control: 71.2 ± 5.6

BMC Musculoskeletal Disorders

2022

Y. Zong

Retrospective case-controlled study

III

Hoehn and Yahr stage

2.3 ± 0.9

PD: 13.8 ± 7.2 months

Control: 14.5 ± 8.3 months

12

48

PD: 65.4 ± 11.4

Control: 65.2 ± 10.9

J of AAOS

2022

Cheppalli

Registry-based case-controlled study

III

No information

4 years

3082

555,289

PD: 71.44 ± 7.88

Control: 66.59 ± 9.50